Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

Men with coeliac disease may have hormone imbalances that could affect sexual function, but these can improve with better gut health.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Sweat gland stem cells help maintain glands, aid wound healing, and can regenerate skin structures.

Cell aging can be both good and bad for tissue repair.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.